Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
Journal Year:
2024,
Volume and Issue:
1871(8), P. 119826 - 119826
Published: Aug. 25, 2024
In
nature,
the
majority
of
known
RNA-protein
interactions
are
transient.
Our
recent
study
has
depicted
a
novel
mechanism
as
RNAylation,
which
covalently
links
proteins
and
RNAs.
This
modification
bridges
realms
RNA
protein
modifications.
review
specifically
explores
RNAylation
catalyzed
by
bacteriophage
T4
ADP-ribosyltransferase
ModB,
with
focus
on
its
targets
substrates
in
context
Escherichia
coli-bacteriophage
interaction.
Additionally,
we
discuss
biological
significance
present
perspectives
versatile
bioconjugation
strategy
for
RNAs
proteins.
Science Advances,
Journal Year:
2022,
Volume and Issue:
8(40)
Published: Oct. 5, 2022
Ubiquitylation
had
been
considered
limited
to
protein
lysine
residues,
but
other
substrates
have
recently
emerged.
Here,
we
show
that
DELTEX
E3
ligases
specifically
target
the
3′
hydroxyl
of
adenosine
diphosphate
(ADP)–ribosyl
moiety
can
be
linked
a
protein,
thus
generating
hybrid
ADP-ribosyl-ubiquitin
modification.
Unlike
known
hydroxyl-specific
E3s,
which
proceed
via
covalent
E3~ubiqutin
intermediate,
enzymes
are
RING
E3s
stimulate
direct
ubiquitin
transfer
from
E2~ubiquitin
onto
substrate.
However,
DELTEXes
follow
previously
unidentified
paradigm
for
whereby
ligase
not
only
forms
scaffold
also
provides
catalytic
residues
activate
acceptor.
Comparative
analysis
hydroxyl-ubiquitylating
active
sites
points
recurring
use
histidine
residue,
which,
in
is
potentiated
by
glutamate
triad-like
manner.
In
addition,
determined
hydrolase
specificity
profile
this
modification,
identifying
human
and
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
could
reverse
it
cells.
Nucleic Acids Research,
Journal Year:
2023,
Volume and Issue:
51(15), P. 8217 - 8236
Published: June 3, 2023
AlphaFold2
and
related
computational
tools
have
greatly
aided
studies
of
structural
biology
through
their
ability
to
accurately
predict
protein
structures.
In
the
present
work,
we
explored
AF2
models
17
canonical
members
human
PARP
family
supplemented
this
analysis
with
new
experiments
an
overview
recent
published
data.
proteins
are
typically
involved
in
modification
nucleic
acids
mono
or
poly(ADP-ribosyl)ation,
but
function
can
be
modulated
by
presence
various
auxiliary
domains.
Our
provides
a
comprehensive
view
structured
domains
long
intrinsically
disordered
regions
within
PARPs,
offering
revised
basis
for
understanding
these
proteins.
Among
other
functional
insights,
study
model
PARP1
domain
dynamics
DNA-free
DNA-bound
states
enhances
connection
between
ADP-ribosylation
RNA
ubiquitin-like
modifications
predicting
putative
RNA-binding
E2-related
RWD
certain
PARPs.
line
bioinformatic
analysis,
demonstrate
first
time
PARP14's
capability
activity
vitro.
While
our
insights
align
existing
experimental
data
probably
accurate,
they
need
further
validation
experiments.
Journal of Biological Chemistry,
Journal Year:
2023,
Volume and Issue:
299(9), P. 105096 - 105096
Published: July 26, 2023
PARP14/BAL2
is
a
large
multidomain
enzyme
involved
in
signaling
pathways
with
relevance
to
cancer,
inflammation,
and
infection.
Inhibition
of
its
mono-ADP-ribosylating
PARP
homology
domain
three
ADP-ribosyl
binding
macro
domains
has
been
regarded
as
potential
means
therapeutic
intervention.
Macrodomains-2
-3
are
known
stably
bind
ADP-ribosylated
target
proteins,
but
the
function
macrodomain-1
remained
somewhat
elusive.
Here,
we
used
biochemical
assays
ADP-ribosylation
levels
characterize
PARP14
homologous
PARP9.
Our
results
show
that
both
macrodomains
display
an
glycohydrolase
activity
not
directed
toward
specific
protein
side
chains.
unable
degrade
poly(ADP-ribose),
enzymatic
product
PARP1.
The
F926A
mutation
F244A
PARP9
strongly
reduced
respective
macrodomains,
suggesting
mechanistic
Mac1
SARS-CoV-2
Nsp3
protein.
This
study
adds
two
new
enzymes
previously
six
human
glycohydrolases.
have
key
implications
for
how
will
be
studied
their
functions
understood.
Pathogens,
Journal Year:
2023,
Volume and Issue:
12(2), P. 324 - 324
Published: Feb. 15, 2023
The
worldwide
public
health
and
socioeconomic
consequences
caused
by
the
COVID-19
pandemic
highlight
importance
of
increasing
preparedness
for
viral
disease
outbreaks
providing
rapid
prevention
treatment
strategies.
NSP3
macrodomain
coronaviruses
including
SARS-CoV-2
is
among
protein
repertoire
that
was
identified
as
a
potential
target
development
antiviral
agents,
due
to
its
critical
role
in
replication
consequent
pathogenicity
host.
By
combining
virtual
biophysical
screening
efforts,
we
discovered
several
experimental
small
molecules
FDA-approved
drugs
inhibitors
macrodomain.
Analogue
characterisation
hit
matter
crystallographic
studies
confirming
binding
modes,
antibiotic
compound
aztreonam,
active
site
provide
valuable
structure–activity
relationship
information
support
current
approaches
open
up
new
avenues
inhibitor
development.
Toxins,
Journal Year:
2024,
Volume and Issue:
16(5), P. 208 - 208
Published: April 28, 2024
Recent
discoveries
establish
DNA
and
RNA
as
bona
fide
substrates
for
ADP-ribosylation.
NADAR
(“NAD-
ADP-ribose”-associated)
enzymes
reverse
guanine
ADP-ribosylation
serve
antitoxins
in
the
DarT-NADAR
operon.
Although
NADARs
are
widespread
across
prokaryotes,
eukaryotes,
viruses,
their
specificity
broader
physiological
roles
remain
poorly
understood.
Using
phylogenetic
biochemical
analyses,
we
further
explore
de-ADP-ribosylation
activity
antitoxin
functions
of
domains.
We
demonstrate
that
different
subfamilies
proteins
from
representative
E.
coli
strains
an
coli-infecting
phage
retain
while
displaying
providing
protection
toxic
cells.
Furthermore,
identify
a
myxobacterial
enzyme
within
YbiA
subfamily
its
associated
DarT-unrelated
ART
toxin,
which
termed
YarT,
thus
presenting
hitherto
uncharacterised
ART-YbiA
toxin–antitoxin
pair.
Our
studies
contribute
to
burgeoning
field
ADP-ribosylation,
supporting
relevance
beyond
bacterial
systems.
Notably,
confinement
non-mammals
infer
potential
highly
specific
targets
antimicrobial
drugs
with
minimal
off-target
effects.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(9), P. 1977 - 1977
Published: Sept. 7, 2022
NAD+
and
ADP-ribose
(ADPr)-containing
molecules
are
at
the
interface
of
virus-host
conflicts
across
life
encompassing
RNA
processing,
restriction,
lysogeny/dormancy
functional
hijacking.
We
objectively
defined
central
components
NAD+-ADPr
networks
involved
in
these
systematically
surveyed
21,191
completely
sequenced
viral
proteomes
representative
all
publicly
available
branches
world
to
reconstruct
a
comprehensive
picture
systems.
These
systems
have
been
widely
repeatedly
exploited
by
positive-strand
DNA
viruses,
especially
those
with
larger
genomes
more
intricate
life-history
strategies.
present
evidence
that
ADP-ribosyltransferases
(ARTs),
ADPr-targeting
Macro,
NADAR
Nudix
proteins
frequently
packaged
into
virions,
particularly
phages
contractile
tails
(Myoviruses),
deployed
during
infection
modify
host
macromolecules
counter
NAD+-derived
signals
restriction.
Genes
encoding
NAD+-ADPr-utilizing
domains
were
exchanged
between
distantly
related
hosts
endo-parasites/symbionts,
suggesting
selection
for
them
virus
world.
Contextual
analysis
indicates
bacteriophage
versions
likely
soluble
ADPr
derivatives,
while
eukaryotic
might
prefer
macromolecular
adducts.
Finally,
we
also
use
comparative
genomics
predict
countering
ADP
ribosylation
molecules.